AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
Why are these penny stocks moving in the stock market today? The post 5 Hot Penny Stocks To Watch With Premarket Momentum & News appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
ObsEva press release (OBSV): FY GAAP EPS of -$0.78 misses by $0.05.Revenue of $20.11M in-line.Cash and cash equivalents of $54.7 million at December 31, 2021 compared…
ObsEva SA (NASDAQ:OBSV) concluded the trading at $1.34 on Friday, February 25 with a rise of 1.52% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.32 and 5Y monthly beta was reading 0.66 with its price kept floating in the range … ObsEva SA (OBSV) Forecast: Revisiting The Past To Gain Insights For The Future Read More »

30 Stocks Moving in Tuesday''s Pre-Market Session

11:45am, Tuesday, 22'nd Feb 2022 Benzinga
Gainers Digital World Acquisition Corp . (NASDAQ: DWAC ) rose 28.5% to $108.31 in pre-market trading. Just hours after launching on Sunday night in Apples App Store, Donald Trump''s new social media app Truth Social encountered a partial outage. Truth Social is an app created by Trump''s new company, Trump Media & Technology Group, which announced a SPAC merger with Digital World Acquisition in October. BRC Inc. (NYSE: BRCC ) rose 25.1% to $23.50 in pre-market trading after gaining around 4% on Friday. Phunware, Inc (NASDAQ: PHUN ) rose 18.8% to $3.78 in pre-market trading. Phunware, recently announced the launch of its PhunToken (PHTK) liquidity pool rewards program. Ocugen, Inc. (NASDAQ: OCGN ) rose 17.1% to $4.05 in pre-market trading. The FDA has lifted its clinical hold on Ocugens investigational new drug application seeking approval to conduct testing of the COVID-19 vaccine Covaxin in the U.S. Healthcare Capital Corp. (NASDAQ: HCCC ) shares rose 13.4% to $11.44 in pre-market trading.
ObsEva (OBSV) signed a licensing agreement with Theramex to support the commercialization and market introduction of linzagolix in markets outside of the U.S., Canada and Asia.OBSV…
ObsEva SA (NASDAQ: OBSV ) said that based on ongoing communications with the European Medicines Agency (EMA), it expects further questions on the linzagolix application, thereby extending the application timeline . ObsEva is in dialogue with the EMA to understand areas that may require further clarification and is committed to promptly addressing any questions that could arise. In December, EMA''s Committee for Medicinal Full story available on Benzinga.com
ObsEva SA  OBSV said that based on ongoing communications with the European Medicines Agency (EMA), it expects further questions on the linzagolix application, thereby extending the application time

ObsEva gains after naming chief strategy officer

02:03pm, Tuesday, 01'st Feb 2022 Seeking Alpha
ObsEva (OBSV) is trading ~7% higher in the pre-market on above-average volume after announcing the appointment of Katja Buhrer as its Chief Strategy Officer and member of the
What to know about trading penny stocks today The post Trading Penny Stocks? Top Stock Market News for February 1st, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc
The stock price of Obseva SA (NASDAQ: OBSV) increased by over 15% pre-market today. This is why it happened.
ObsEva (OBSV) announced that its board of directors approved a decision on Jan

7 Penny Stocks to Buy for January

03:04pm, Monday, 10'th Jan 2022
These penny stocks look poised for a rally in January 2022 and can possibly deliver multi-fold returns in the next 12 months. The post 7 Penny Stocks to Buy for January appeared first on InvestorPlace

ObsEva SA. Shares Near 52-Week Low - Market Mover

09:32am, Monday, 10'th Jan 2022 Kwhen Finance
ObsEva SA. (OBSV) shares closed today at 1.6% above its 52 week low of $1.91, giving the company a market cap of $165M. The stock is currently down 2.5% year-to-date, down 7.6% over the past 12 months, and down 83.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 340.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 864.1% The company's stock price performance over the past 12 months lags the peer average by 2.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

ObsEva SA. Shares Approach 52-Week Low - Market Mover

05:48am, Sunday, 09'th Jan 2022 Kwhen Finance
ObsEva SA. (OBSV) shares closed today at 1.6% above its 52 week low of $1.91, giving the company a market cap of $165M. The stock is currently down 2.5% year-to-date, down 6.7% over the past 12 months, and down 83.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 340.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 864.1% The company's stock price performance over the past 12 months beats the peer average by -23.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

ObsEva SA. Shares Approach 52-Week Low - Market Mover

02:15am, Friday, 07'th Jan 2022 Kwhen Finance
ObsEva SA. (OBSV) shares closed today at 1.5% above its 52 week low of $1.97, giving the company a market cap of $175M. The stock is currently up 3.5% year-to-date, down 5.5% over the past 12 months, and down 82.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 42.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 391.1% The company's stock price performance over the past 12 months beats the peer average by -28.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE